Mon, March 16, 2020

Raghuram Selvaraju Maintained (ADMA) at Strong Buy with Decreased Target to $12 on, Mar 16th, 2020

Raghuram Selvaraju of HC Wainwright & Co., Maintained "ADMA Biologics, Inc." (ADMA) at Strong Buy with Decreased Target from $14 to $12 on, Mar 16th, 2020.

Raghuram, nor any peers, have made any analyst calls on ADMA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30


Similar Stocks and Investing Publications